HIGHLIGHTS
- who: Yuan Gu et al. from the Institute for Clinical and Experimental Surgery, Saarland University, Homburg, Germany have published the paper: Brassinin Promotes the Degradation of Tie2 and FGFR1 in Endothelial Cells and Inhibits Triple-Negative Breast Cancer Angiogenesis, in the Journal: Cancers 2022, x of /2022/
- what: The authors demonstrated in vitro that preferentially reduces the viability of endothelial cells (ECs) when compared to other cell types of the tumor microenvironment including TNBC cells pericytes and fibroblasts. The authors demonstrate for the first time that brassinin inhibits TNBC growth preferentially through inhibiting the angiogenic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.